Hemoglobin

Papers
(The TQCC of Hemoglobin is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Prevalence and Management of β-Thalassemia in India15
β-Thalassemia Major and Coronavirus-19, Mortality and Morbidity: a Systematic Review Study14
Association between Hb A1c and Severity of COVID-19 Patients11
Thalassemia in Thailand11
Incidence Rate of COVID-19 Infection in Hemoglobinopathies: A Systematic Review and Meta-analysis10
Thalassemia in Pakistan9
Hb Bart’s Hydrops Fetalis Syndrome and Hb H Disease Caused by Deletional Chiang Rai (– –CR) α0-Thalassemia in Two Unrelated Thai Families9
Thalassemia in Indonesia9
Adherence to Iron Chelation Therapy among Adults with Thalassemia: A Systematic Review9
Perforated Duodenal Ulcer Associated with Deferasirox in a Child with β-Thalassemia Major8
Hb Hezhou [β64(E8)Gly→Ser; HBB: c.193G>A]: A Novel Variant on the β-Globin Gene8
High Prevalence of Anemia and Inherited Hemoglobin Disorders in Tribal Populations of Madhya Pradesh State, India8
Thalassaemia Registries: A Call for Action. A Position Statement from the Thalassaemia International Federation8
THALASSEMIA in ASIA 2021: Thalassemia in Guangxi Province, People’s Republic of China8
COVID-19 and Anemia: What Do We Know So Far?8
Thalassemia in Malaysia8
Glucose-6-Phosphate Dehydrogenase Deficiency: An Overview of the Prevalence and Genetic Variants in Saudi Arabia8
Utilization of Pneumococcal Vaccine and Penicillin Prophylaxis in Sickle Cell Disease in Three African Countries: Assessment among Healthcare Providers in SickleInAfrica8
Haptoglobin Genotypes Associated with Vaso-Occlusive Crisis in Sickle Cell Anemia Patients of Eastern India7
Quality of Life and Related Factors in β-Thalassemia Patients7
The Prevention of Thalassemia Revisited: A Historical and Ethical Perspective by the Thalassemia International Federation7
Thalassemia in Asia 2021 Overview of Thalassemia and Hemoglobinopathies in Bangladesh6
Venous Thromboembolism in Sickle Cell Disease is Associated with Neutrophilia6
Molecular Spectrum of β-Thalassemia Mutations in Central to Eastern Thailand6
Comparative Efficacy and Safety Between Deferiprone and Deferasirox with Special Reference to Serum Ferritin Level and Cardiac Function in Bengali β-Thalassemia Major Children5
Upregulation of miR-214 Mediates Oxidative Stress in Hb H DiseaseviaTargeting ofATF45
Transcranial Doppler Velocities among Sickle Cell Disease Patients in Steady State5
Spectrum of β-Thalassemia and Other Hemoglobinopathies in the Saurashtra Region of Gujarat, India: Analysis of a Large Population Screening Program5
The Prevalence of Hypothyroidism among Patients With β-Thalassemia: A Systematic Review and Meta-Analysis of Cross-Sectional Studies5
A Novel α-Globin Chain Variant, Hb Nanchang [HBA2: c.46G>A, Codon 15 (GGT>AGT) (Gly→Ser)], Detected by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectr5
Detection of an α-Globin Fusion Gene Using Real-Time Polymerase Chain Reaction-Based Multicolor Melting Curve5
Correlation Between Serum Ferritin and Viral Hepatitis in Thalassemia Patients5
Hb Mizuho (HBB: c.206T>C): Pitfalls of Screening Tests in an Unstable Hemoglobin Variant Diagnosed after Targeted Next-Generation Sequencing4
Hemoglobinopathies and COVID-19: The Experience of a Center in Northern Greece4
Updated Molecular Spectrum of β-Thalassemia Mutations in Duhok Province, Northern Iraq: Ethnic Variation and the Impact of Immigration4
Hb A2-Calderdale [δ2(NA2)His→Asn; HBD: c.7C>A] and Misdiagnosis of Type 2 Diabetes Mellitus Due to Interference with Hb A1c When Using Cation Exchange High Performance 4
A Study to Assess and Improve Adherence to Iron Chelation Therapy in Transfusion-Dependent Thalassemia Patients4
Comparison of Hematopoietic Stem Cell Transplantation Results in Patients with β-Thalassemia Major from Three Different Graft Types3
Spectrum of β-Thalassemia Mutations in Some Areas of Guangxi Zhuang Autonomous Region of Southern China: A Study on a Pediatric Population Aged 0–15 Years3
Thalassemia in Viet Nam3
Iron Chelators, Such as Deferasirox, When Combined With Hydroxyurea, Provide an Additional Benefit of Iron Chelation in Patients Receiving Chronic Transfusion Therapy3
Current Status of β-Thalassemic Burden in India3
Development of the Quality of Life Questionnaire (SF-36) for Patients with β-Thalassemia Major and β-Thalassemia Intermedia Based on Extended Rasch Analysis3
Combined Gap-Polymerase Chain Reaction and Targeted Next-Generation Sequencing Improve α- and β-Thalassemia Carrier Screening in Pregnant Women in Vietnam3
Calcium Channel Blockers in Conjunction with Standard Iron-Chelating Agents for β-Thalassemia Major: Systematic Literature Search3
Thalassemia in Asia 2021 Thalassemia in Brunei Darussalam3
A New Case of Hb Headington (HBB: c.217A>C) Due to a New DNA Transversion, Found in a Patient with Type 2 Diabetes Mellitus3
Compound Heterozygosity for a Novel Mutation Codon 104 (–A) (HBB: c.313delA) and Codons 41/42 (–CTTT) (HBB: c.126_129delCTTT) Leading to β-Thalassemia Major in a Chinese Family3
High Systolic Blood Pressure, Anterior Segment Changes and Visual Impairment Independently Predict Sickle Cell Retinopathy2
Hb F Levels in β-Thalassemia Carriers and Normal Individuals: Known and Unknown Quantitative Trait Loci in the β-Globin Gene Cluster2
The Changing Trends in Prenatal Diagnosis of Hemoglobinopathies in India: The Quest of a Single Center to Reduce the Burden of Disease over Three Decades2
First Report of the 3'-Untranslated Region +1506 (A>C) [NM_000518.5: c.*32A>C] mutation on the β-Globin Gene in the Indian Population2
An Evaluation for the Causes of Reduced Hb A2 and the Molecular Characterization of HBD Variants in Hong Kong2
Total Annual Economic Burden of Patients with Sickle Cell Disease in Steady State in Greece2
A Novel Hemoglobin Variant Hb Liaobu [α107(G14)Val→Leu, HBA2: c.322G>C] Detected by Matrix-Assisted Laser Desorption Ionization-Time-of-Flight Mass Spectrometry2
A Rare Case of Abnormal Hemoglobin Variant Hb Mizuho: [HBB: c.206T > C β 68(E12) Leu-Pro]: A First Report in the Chinese Population2
Novel Insights into the Pathophysiology and Treatment of Sickle Cell Disease2
Hb Lepore-Hong Kong: First Report of a Novel δ/β-Globin Gene Fusion in a Chinese Family2
Clinical Features and Outcome of Sickle Cell Disease in a Tertiary Center in Northern Lebanon: A Retrospective Cohort Study in a Local, Hospital-Associated Registry2
Thalassemia in India2
Haploidentical Hematopoietic Stem Cell Transplantation in Thalassemia2
The Prevalence of HBB Mutations among the Transfusion-Dependent and Non Transfusion-Dependent Hb E/β-Thalassemia Children in a Tertiary Center of West Bengal, India2
Hepcidin-to-Ferritin Ratio as an Early Diagnostic Index of Iron Overload in β-Thalassemia Major Patients2
Bringing Sickle Cell Disease Care Closer to Home: Feasibility and Efficacy of a Quality Improvement Initiative at a Community Hospital2
Evaluation of the High Resolution Melting Approach for Detection of β-Thalassemia Gene Mutations2
Dominantly Inherited β-Thalassemia Caused by a Single Nucleotide Deletion in Exon 3 of the β-Globin Gene: Hb Xiangyang (HBB: c.393delT)2
Surrogate Markers of Subclinical Atherosclerosis and Its Associated Factors in Patients with β-Thalassemia Major2
Profiling of 35 Cases of Hb S/Hb E (HBB: c.20A>T/HBB: c.79G>a), Disease and Association with α-Thalassemia and β-Globin Gene Cluster Haplotypes from Odisha, India2
Inner Ear Complications in Children and Adolescents with Sickle Cell Disease2
Hb S (HBB: c.20A>T) Characteristics by High Performance Liquid Chromatography in Patients with Sickle Cell Disease Receiving the Novel Agent Voxelotor2
An Autopsy Case of β-Thalassemia Major Illuminating the Pathological Spectrum of the Disease2
Thalassemia in Sri Lanka2
Serum Zinc Level in β-Thalassemia Major: A Retrospective Study in Southwest Iran2
Exploration of Barriers and Facilitators to Optimal Emergency Department Care of Sickle Cell Disease: Opportunities for Patient–Physician Partnerships to Improve Care2
An Expert Overview on Therapies in Non-Transfusion-Dependent Thalassemia: Classical to Cutting Edge in Treatment2
0.042931079864502